BIG DNA LTD has a total of 24 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2008. It filed its patents most often in United Kingdom, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are PELLEPHARM INC, THERAMARK LIMITED and AZANTA DANMARK AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 9 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | China | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | March John Bernard | 13 |
#2 | Clark Ewan Mcintosh | 12 |
#3 | John Bernard March | 3 |
#4 | Ewan Mcintosh Clark | 1 |
#5 | Ewan Mclntosh Clark | 1 |
#6 | Ewan Macintosh Clark | 1 |
#7 | Clark Jason Richard | 1 |
Publication | Filing date | Title |
---|---|---|
GB2554333A | Combination therapy | |
CN106999540A | Combination treatment | |
GB201506673D0 | Combination therapy | |
GB201500681D0 | Combination therapy | |
GB201419311D0 | Combination therapy | |
GB201417343D0 | Prodrugs of bortezomib | |
GB201417348D0 | Prodrugs of lxazomib | |
GB201417347D0 | Prodrugs of delanzomib | |
GB201414132D0 | Prodrugs of bortezomib | |
GB0808780D0 | Fish vaccines |